Diapositive 1

293 / 1851

Intergroup Trial INT 0123
High dose
(64.8 Gy)
Standard
dose
(50.4 Gy)
No pts 109 109
Treatment-
related deaths
10% 2%
2-yr survival
(%)
31% 40%